E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia

Leukemia

Volumn 22, Issue 4, 2008, Pages 723-729

  Zhong, C H ^a,b   Prima, V ^a,b   Liang, X ^c   Frye, C ^a,b   McGavran, L ^c,d   Meltesen, L ^c   Wei, Q ^e   Boomer, T ^f   Varella Garcia, M ^c,d   Gump, J ^f   Hunger, S P ^a,b,e,f  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^e CHILDREN S HOSPITAL   (United States)

^f Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; ONCOPROTEIN; PROTEIN NOL1; PROTEIN ZNF384; RNA; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME 12; CHROMOSOME TRANSLOCATION; CORD BLOOD STEM CELL TRANSPLANTATION; DIMERIZATION; DNA BINDING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; INTRON; LEUKEMIA RELAPSE; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

EID: 42249116186     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405084     Document Type: Article

References (33)

1. Hunger SP. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: Clinical features and molecular pathogenesis. Blood 1996; 87: 1211-1224.
2. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535-545.
3. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547-555.
4. Hunger SP, Ohyashiki K, Toyama K, Cleary ML. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 1992; 6: 1608-1620.
5. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992; 257: 531-534.
6. Hunger SP, Devaraj PE, Foroni L, Secker-Walker LM, Cleary ML. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood 1994; 83: 2970-2977.
7. Yoshihara T, Inaba T, Shapiro LH, Kato JY, Look AT. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 1995; 15: 3247-3255.
8. Honda H, Inaba T, Suzuki T, Oda H, Ebihara Y, Tsuiji K et al. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Blood 1999; 93: 2780-2790.
9. Smith KS, Rhee JW, Naumovski L, Cleary ML. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol Cell Biol 1999; 19: 4443-4451.
10. Kamps MP, Look AT, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 1991; 5: 358-368.
11. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: Fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 1994; 14: 8304-8314.
12. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS et al. Chimerie homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 1993; 74: 833-843.
13. Brambillasca F, Mosna G, Colombo M, Rivolta A, Caslini C, Minuzzo M et al. Identification of a novel molecular partner of the E2A gene in childhood leukemia. Leukemia 1999; 13: 369-375.
14. Hunger SP, Sun T, Boswell AF, Carroll AJ, McGavran L. Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature. Genes Chromosomes Cancer 1997; 20: 392-398.
15. Mitelman F (ed). ISCN. An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1995.
16. Boomer T, Varella-Garcia M, McGavran L, Meltesen L, Olsen AS, Hunger SP. Detection of E2A translocations in leukemias via fluorescence in situ hybridization. Leukemia 2001; 15: 95-102.
17. Suryanarayan K, Hunger SP, Kohler S, Carroll AJ, Crist W, Link MP et al. Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood 1991; 77: 324-330.
18. Mellentin JD, Murre C, Donlon TA, McCaw PS, Smith SD, Carroll AJ et al. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989; 246: 379-382.
19. Ochs RL, Reilly MT, Freeman JW, Busch H. Intranucleolar localization of human proliferating cell nucleolar antigen p120. Cancer Res 1988; 48: 6523-6529.
20. Alvarez M, Long H, Onyia J, Hock J, Xu W, Bidwell J. Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 1997; 138: 482-489.
21. Nakamoto T, Yamagata T, Sakai R, Ogawa S, Honda H, Ueno H et al. CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases. Mol Cell Biol 2000; 20: 1649-1658.
22. Gorczyca W, Bruno S, Melamed MR, Darzynkiewicz Z. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: Effects of methotrexate, camptothecin, and teniposide. Cancer Res 1992; 52: 3491-3494.
23. Trere D, Migaldi M, Montanaro L, Pession A, Derenzini M. p120 expression provides a reliable indication of the rapidity of cell duplication in cancer cells independently of tumour origin. J Pathol 2000; 192 216-220.
24. Perlaky L, Valdez BC, Busch RK, Larson RG, Jhiang SM, Zhang WW et al Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res 1992; 52: 428-436.
25. Feister HA, Torrungruang K, Thunyakitpisal P, Parker GE, Rhodes SJ, Bidwell JP. NP/NMP4 transcription factors have distinct osteoblast nuclear matrix subdomains. J Cell Biochem 2000; 79: 506-517.
26. Thunyakitpisal P, Alvarez M, Tokunaga K, Onyia JE, Hock J, Ohashi N et al. Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts. J Bone Miner Res 2001; 16: 10-23.
27. Martini A, La Starza R, Janssen H, Bilhou-Nabera C, Corveleyn A, Somers R et al. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res 2002; 62: 5408-5412.
28. Hunger SP, Zhong C. Cryptic t(12;19) in ALL with lineage switch to AML creates two new E2A fusion proteins. Blood 2002; 100: 529a (Abstract no. 2070).
29. Corveleyn A, Janssen H, Martini A, Somers R, Cools J, Marynen P. Cellular transformation of NIH3T3 fibroblasts by CIZ/NMP4 fusions. J Cell Biochem 2005; 94: 1112-1125.
30. La Starza R, Aventin A, Crescenzi B, Gorello P, Specchia G, Cuneo A et al. CIZ gene rearrangements in acute leukemia: Report of a diagnostic FISH assay and clinical features of nine patients. Leukemia 2005; 19: 1696-1699.
31. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004; 18: 895-908.
32. Barber KE, Harrison CJ, Broadfield ZJ, Stewart AR, Wright SL, Martineau M et al. Molecular cytogenetic characterization of TCF3 (E2A)/ 19p13:3 rearrangements in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 2007; 46: 478-486.
33. Tanabe S, Bohlander SK, Vignon CV, Espinosa III R, Zhao N, Strissel PL et al. AF10 is split by MLL and HEAB, a human homolog to a putative Caenorhabditis elegans ATP/GTP-binding protein in an invins(10;11)(p12;q23q12). Blood 1996; 88: 3535-3545.